ClinicalTrials.Veeva

Menu

The Clinical Significance of Sentinel Lymph Node Imaging Combined With Imaging Examination in Pelvic and Peritoneal Lymphadenectomy for Endometrial Carcinoma

S

Second Affiliated Hospital of Wenzhou Medical University

Status

Unknown

Conditions

Endometrial Carcinoma
Lymphadenectomy

Treatments

Procedure: Pelvic and Peritoneal Lymphadenectomy

Study type

Interventional

Funder types

Other

Identifiers

NCT03877627
SAHoWMU-CR2019-07-102

Details and patient eligibility

About

The aim of this prospective cohort study is to explore the clinical significance of sentinel lymph node imaging combined imaging examination evaluation in pelvic and peritoneal lymphadenectomy for endometrial carcinoma management.

Full description

The clinical data including surgical procedure, the situation of sentinel lymph node imaging and pathological results of patients with endometrial carcinoma treated in our hospitals between April 2019 and April 2021 will be analyzed in this study to clarify the homogeneity of imaging evaluation, sentinel lymph node development evaluation and pathological results.

Enrollment

60 estimated patients

Sex

Female

Ages

10 to 90 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Females who are diagnosed with endometrial carcinoma;
  2. Patients who are willing to receive primary non-reserved fertility function surgery to treat their disease;
  3. Patients who are agreed to participated in this prospective cohort study.

Exclusion criteria

  1. Patients who still have the will to have pregnancy;
  2. Patients who have other diseases or heavy injuries that will interfere with the results;
  3. Simultaneous participation in another clinical study with investigational medicinal product(s) or researcher thinks the subjects are not suitable for this trial.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

60 participants in 2 patient groups

Negative 1
No Intervention group
Description:
Patients in this arm will not undergo Pelvic and Peritoneal Lymphadenectomy.
Negative 2
Experimental group
Description:
Patients in this arm will undergo Pelvic and Peritoneal Lymphadenectomy.
Treatment:
Procedure: Pelvic and Peritoneal Lymphadenectomy

Trial documents
1

Trial contacts and locations

0

Loading...

Central trial contact

Yu ZHAO, Ph.D

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems